RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 69 filers reported holding RECRO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $48,000 | -56.4% | 10,600 | -21.5% | 0.00% | – |
| Q1 2020 | $110,000 | -79.1% | 13,500 | -53.0% | 0.00% | -100.0% |
| Q4 2019 | $526,000 | +65.4% | 28,700 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $318,000 | +29.3% | 28,700 | +18.6% | 0.00% | 0.0% |
| Q2 2019 | $246,000 | +77.0% | 24,200 | +2.1% | 0.00% | – |
| Q1 2019 | $139,000 | +6.9% | 23,700 | +29.5% | 0.00% | – |
| Q4 2018 | $130,000 | +66.7% | 18,300 | +66.4% | 0.00% | – |
| Q3 2018 | $78,000 | +41.8% | 11,000 | 0.0% | 0.00% | – |
| Q2 2018 | $55,000 | -54.5% | 11,000 | 0.0% | 0.00% | – |
| Q1 2018 | $121,000 | +18.6% | 11,000 | 0.0% | 0.00% | – |
| Q4 2017 | $102,000 | +3.0% | 11,000 | 0.0% | 0.00% | – |
| Q3 2017 | $99,000 | +28.6% | 11,000 | 0.0% | 0.00% | – |
| Q2 2017 | $77,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |